Citations

Clear

680 citation(s) found for "Thörn, Emma".

Life-Course Blood Pressure Trajectories and Focal Myocardial Fibrosis in Older Age in MyoFit46
Topriceanu, Constantin-Cristian , Shiwani, Hunain , Martin, Emma , Falconer, Debbie , Bennett, Jonathan B. , Stanley, Matthew A , Gonzalez-Martin, Pablo , Tamang, Mansoon , Wong, Andrew , Pierce, Iain , Davies, Rhodri H , Lambiase, Pier D , Chaturvedi, Nishi , Kellman, Peter , Hardy, Rebecca , Moon, James C , Hughes, Alun D , Captur, Gabriella

Mayo Clinic

Hypertension | October 19, 2026 | Volume: 83 | Issue: 12 | Pages: No page available

10.1161/hypertensionaha.126.26702 | PMID 42895024 Get It

BACKGROUND: The impact of life-course blood pressure (BP) trajectories on later-life focal left ventricular (LV) fibrosis by late gadolinium enhancement (LGE) remains elusive. METHODS: MyoFit46 prospectively recruited ≈500 participants from the 1946 National Survey of Health and Development birth cohort for a cardiovascular magnetic resonance scan at 77 years, assessing LV LGE mass (in grams), calculated using the 3-SD (LGE 3SD ) or 5-SD (LGE 5SD ) methods. Cross-sectional systolic (SBPs) and diastolic BPs (DBPs) were recorded at 36, 43, 53, 63, 69, and 77 years. For each participant and age interval, annual rates of BP change (steepness) were calculated using the observed BPs, and areas under the BP trajectory curve (cumulative burden) were derived using mixed-effects models. Associations between life-course BPs and LV LGE were tested using generalized linear models, adjusted for antihypertensives, demographics, lifestyle, and comorbidities. Time-to-event associations between LV LGE and incident major adverse cardiovascular events (MACE = hospitalizations for coronary artery disease, stroke, heart failure, and atrial/ventricular arrhythmias; N=29 events) were also evaluated. RESULTS: Among 472 participants (54% were men), each 10 mm Hg increment in cross-sectional SBPs at 36 to 69 years was associated with 6% to 11% greater LV LGE 3SD (all P ≤0.033), whereas each sustained 10 mm Hg greater SBP over any age interval from 36 to 69 was associated with 16% to 24% greater LV LGE 3SD at 77 years (all P ≤0.005), with all associations independent of SBP at 77 years. Each 1 mm Hg/y steeper SBP rise during age intervals 36 to 43, 43 to 53, and 53 to 63 years was associated with 6% to 12% greater LV LGE 3SD at 77 years. Results were similar if LV LGE 5SD was used instead. Fewer associations were significant for DBPs. The qualitative presence of LV LGE was associated with greater incident MACE rates (hazard ratio, 2.5 [95% CI, 1.2–5.2]). CONCLUSIONS: Higher life-course cross-sectional BPs, greater cumulative burden, and steeper BP increases were associated with greater LV LGE burden in older age, which was linked to incident MACE. BP trajectories, beyond single-point BP measurements, warrant further investigation as tools to guide BP management strategies.
Inducible Laryngeal Obstruction in Hypermobile Patients
Thompson, Chandler C. , Menton, Stacey M , Wilson, Frances C , Zangerle, Derek J. , Murphy, Emma F. , Darakjian, Ashley A , Gajarawala, Shilpa , Knight, Dacre R T , Bruno, Katelyn A , Rutt, Amy L.

Mayo Clinic

The Laryngoscope | October 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/lary.70980 | PMID 42860825 Get It

ABSTRACT Objective To determine whether patients with hypermobile Ehlers‐Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD) and inducible laryngeal obstruction (ILO) have more voice, cough, swallowing, GI issues, and MC activation than patients without ILO. Methods This retrospective study of 2162 patients meeting 2017 diagnostic criteria for hEDS ( n = 507) or HSD ( n = 1655) who were seen at the EDS Clinic in Mayo Clinic Florida from November 2019 to June 2025 compared patients who screened positive for ILO to those who screened negative. Patients were examined for self‐reported symptoms of voice, cough, swallow, and GI issues as well as MC activation. Results Among patients with hEDS or HSD, 23.1% and 17.1% respectively screened positive for ILO. Patients with ILO had significantly more voice, cough, and swallow issues than patients without ILO (all p ≤ 0.007). Both diagnoses had more gastroesophageal reflux disease (GERD) (hEDS: 55.6% vs. 40.9%, p = 0.004; HSD: 55.8% vs. 42.2%, p < 0.0001). Additionally, both hEDS and HSD patients with ILO self‐reported 18 allergy‐related symptoms more often than those without ILO and had higher MC scores indicating widespread MC activation (all p < 0.0001). Cough, dysphagia, and elevated MC score were statistically significant predictors of ILO in both hEDS and HSD within a logistic regression analysis. Conclusions Chronic cough, dysphagia, and elevated MC symptom burden were the strongest independent predictors of ILO across both hEDS and HSD, underscoring the need for routine multidisciplinary laryngeal assessment in this population. Level of Evidence 3.
To Lengthen or Revise: Reevaluating Anterior Acetabular Overhang Thresholds in Iliopsoas Impingement After Total Hip Arthroplasty
Clark, David S , Yanamala, Sandeep R , Helgeson, Emma E , Berry, Daniel J , Levy, Bruce A , Taunton, Michael J

Mayo Clinic

Journal of Bone and Joint Surgery | October 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.2106/jbjs.26.00011 | PMID 42853909 Get It

Background: Iliopsoas impingement (IPI) is a known cause of persistent anterior hip pain following total hip arthroplasty (THA). Management of IPI has often relied on an 8-mm anterior acetabular overhang threshold to guide operative treatment, favoring acetabular revision for greater overhang and iliopsoas tenotomy for lesser overhang. These thresholds were initially established on the basis of the outcomes of open tenotomy, and now, with an improved understanding of IPI and the advent of arthroscopic iliopsoas fractional lengthening (IPFL), a review of the 8-mm threshold is warranted. Methods: A retrospective review was performed to identify patients who underwent arthroscopic IPFL following primary THA between 2017 and 2024, with a minimum follow-up of 1 year. Acetabular overhang was measured for all patients using cross-table lateral radiographs, and patients were stratified into <8-mm and ≥8-mm cohorts. Patient-reported outcome measures, reoperations, revisions, and complications were collected and analyzed on the basis of both the classic 8-mm threshold and continuous statistical methods. Results: We evaluated 86 hips undergoing IPFL. There were 83 patients (30 men and 53 women), with a mean age of 63.0 ± 11.2 years; with regard to race, 80 patients were White, 1 patient was Black or African American, and 2 patients listed other race or chose not to disclose. The acetabular overhang was <8 mm for 67 hips and ≥8 mm for 19 hips. The mean follow-up was 2.5 ± 1.6 years (range, 1 to 7.5 years). When comparing patients with <8-mm and ≥8-mm acetabular overhang, we observed no significant differences (p > 0.06) in the preoperative and postoperative visual analog scale (VAS) pain scores, modified Harris hip score, Single Assessment Numeric Evaluation (SANE) score, Tegner activity level, subjective groin pain improvement, subjective hip flexion strength improvement, and overall satisfaction. Reoperation (2.9% compared with 10.5%; p = 0.210) and acetabular revision rates (1.5% compared with 5%; p = 0.387) were not significantly different between the <8-mm and ≥8-mm overhang groups. Conclusions: Arthroscopic IPFL provided satisfactory outcomes for patients with IPI, independent of the magnitude of acetabular overhang. IPFL should be considered for first-line surgical management of IPI refractory to nonoperative management, even in the setting of substantial acetabular overhang, given positive outcomes and low rates of subsequent acetabular revision. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Increased stress in early life epigenetically rewires pathways related to aging and longevity
Olova, Nelly N , Zhou, Tianchi , Boner, Winnie , Gillespie, Robert, Ivimey-Cook, Edward R. , Marioni, Riccardo, Cunningham, Emma J. A., Chandra, Tamir, Little, Tom J , Monaghan, Pat, Dominoni, Davide M

Mayo Clinic

No container title available | October 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.30.755600 Get It

Environmental conditions experienced early in life have profound consequences for vertebrate health, yet the molecular pathways linking developmental stress to aging and reduced lifespan remain poorly understood. Through a novel highly accurate epigenetic clock, developed from RRBS-based blood DNA methylation profiles, we show that experimental lifespan-reducing early-life stress rapidly accelerates epigenetic age in zebra finch chicks (Taeniopygia guttata). Corticosterone-treated 29-day-old chicks share differentially methylated loci with non-treated aged birds and cluster with 6-month-old birds. The transcriptional repressor ZBTB16 emerges as an epigenetically top age-correlated gene and is strongest affected by corticosterone. Elevated developmental corticosterone causes rapid epigenetic remodelling of metabolic pathways well-established in aging and longevity. Our results demonstrate epigenetic rewiring of the aging trajectory through conserved stress-survival mechanisms immediately following elevated early-life stress exposure.
Maladaptive Piezo1 Mechanotransduction Drives Smooth Muscle Aging in the Gut
Joshi, Vikram , Seavey, Corey, Knutson, Kaitlyn, Sawant, Abhilash, Hamed, Yasmeen M F , D'Ambrosio, Mario, Laible, Emma, Sinnwell, Jason Paul, Liu, Yuanhang , Jin, Franco F, Thomas, C. T., Garramone, Gwyneth, Mazzone, Amelia Paul, Du, Peng , Grover, Madhusudan , Kashyap, Purna , Druliner, Brooke R. , Cipriani, Gianluca , Marshall, Kara L. , Farrugia, Gianrico, Joshi, Vikram , Seavey, Corey , Knutson, Kaitlyn R. , D’Ambrosio, Mario , Sinnwell, Jason P. , Garramone, Gwyneth K., Mazzone, Amelia , Bonfiglio, Ferdinando , D’Amato, Mauro , Avci, Recep , Linden, David R. , Bae, Yongho , Farrugia, Gianrico , Beyder, Arthur , Dokic, Vladimir, Druliner, Brooke , Beyder, Arthur

Mayo Clinic

No container title available | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.02.748183 | PMID 42818261 Get It

Age-related gastrointestinal dysfunction is common, but the mechanisms of aging-associated smooth muscle failure remain unclear. We show that aging in mice slows whole gut and colonic transit, increases regional stiffness, and reduces smooth muscle contractility. Inducible smooth muscle cell (SMC)– specific deletion of Piezo1 preserved youthful transit and force generation, whereas Piezo1 activation in young mice phenocopied aging-associated transit delay. Single-cell transcriptomics, RNA velocity, stiffness-controlled cell and tissue cultures, and pharmacologic studies revealed that Piezo1 couples increased stiffness to Ca 2+ –calcineurin–NFAT signaling, loss of contractile gene programs, leading to age- related contractile loss and contractile-to-synthetic SMC remodeling and gut wall stiffening. Human intestinal SMCs supported conservation of this pathway, and PIEZO1 gain-of-function carriers showed a trend toward delayed colonic transit. Thus, maladaptive SMC Piezo1 mechanotransduction is a targetable mechanism of aging-associated gut dysmotility. Aging alters organ structure, yet how these changes drive functional decline remains poorly defined. We show that progressive stiffening of the gut with age activates the mechanosensitive ion channel Piezo1 in smooth muscle cells, initiating a maladaptive response that impairs contractility and slows intestinal transit. On the other hand, deletion of smooth muscle Piezo1 prevents age-related gut dysmotility. These findings reveal that age-related physical shifts actively drive functional decline through mechanotransduction pathways. By identifying Piezo1 as a critical link between tissue mechanics and organ aging, this work provides a framework for understanding how mechanical cues contribute to age-related dysfunction in the gut and possibly other smooth muscle organs.
Application of CLIR-Based Post-Analytical Tools to Dutch NBS Data Demonstrates Its Potential Impact on the Performance of CPT1, GA-1, IVA and MSUD Screening in a Disorder-Specific Way
Meijer, Nils W. F., Maase, Rose, Hall, Patricia L., Visser, Wouter F. , Koop, Klaas , Heiner‐Fokkema, M. Rebecca , Velden, Monique G.M. de Sain–van der , Bosch, Annet M , Heiner-Fokkema, M Rebecca , de Sain-van der Velden, Monique G M

Mayo Clinic

International Journal of Neonatal Screening | August 24, 2026 | Volume: 12 | Issue: 3 | Pages: 70

10.3390/ijns12030070 | PMID 42782614 Get It

Newborn screening (NBS) for inborn errors of metabolism is challenged by high false-positive rates, which may lead to parental anxiety and increased healthcare costs associated with diagnostic follow-up. False-positive results often arise from changes in metabolite concentrations that mimic metabolic disorders as a consequence of differences in perinatal factors or nutritional status. To address this, Collaborative Laboratory Integrative Reports (CLIR) and the associated post-analytical tools (PATs) using multivariate interpretation and covariate-adjusted reference intervals may be used to improve specificity of NBS algorithms. In the current study, we examined whether CLIR can be applied to optimize the Dutch NBS program by reducing the false-positive rates. We developed and validated a CLIR-based PAT for CPT1 deficiency, GA-I, IVA and MSUD within the Dutch NBS program. Single-condition tools (SCTs) and multivariate approaches, including marker ratios and covariate adjustments, were evaluated for their ability to discriminate true- and false-positive referrals. For CPT1 deficiency, age-adjusted SCT combined with birthweight, location correction, and the C18:1/methionine ratio substantially reduced false positives. For GA-I, C3DC-based ratios improved specificity while preserving true-positive detection, potentially reflecting postnatal renal immaturity in some cases. For IVA, the dual scatter plot fully separated true- and false-positive referrals, highlighting the limitations of single-marker screening. For MSUD, differences between false-positive and true-positive cases were more pronounced, yet a similar number of false positives were still referred; valine-related markers contributed to false positives, while leucine and the Xle/Phe ratio better identified true positives. CLIR-based post-analytical tools enhanced NBS specificity through covariate-aware, multivariate interpretation. This provides important input for decision makers in both the Dutch NBS, as well as the NBS community worldwide.
Performance of general-population breast cancer risk prediction models in an international consortium
Brantley, Kristen D. , Ahearn, Thomas U, Norton, Emily , MacInnis, Robert, Palmer, Julie R, Vachon, Celine M, Beane-Freeman, Laura, Frost, Reuben, Zirpoli, Gary, Neuhouser, Marian L, Barnett, Matthew, Teras, Lauren R, Patel, Alpa V, Bodelon, Clara, Spielfogel, Emma S. , Kirsh, Victoria A. , Langseth, Hilde , Milne, Roger L, Haiman, Christopher, Scott, Christopher G, Eliassen, A. Heather, Rosner, Bernard, Willett, Walter C, Chen, Yu, Wu, Fen , Zheng, Wei, Long, Jirong, O'Brien, Katie M, Sandler, Dale P, Linet, Martha S. , Anderson, Garnet, Larson, Joseph C. , Lee, I-Min, Chatterjee, Nilanjan, Kraft, Peter, Brantley, Kristen D , Kirsh, Victoria A , Ahearn, Thomas U. , Norton, Emily L., Palmer, Julie R. , Fortner, Renée T. , Vachon, Celine M. , González, Amy Berrington de , Bertrand, Kimberly A. , Zirpoli, Gary , Barnett, Matthew J , Teras, Lauren R. , Hodge, James M. , Patel, Alpa V , Bodelón, Clara , Lacey, James V. , Rohan, Thomas E. , Tsuruda, Kaitlyn M. , Milne, Roger L , Rosner, Bernard, Willett, Walter C. , Romanos-Nanclares, Andrea , Zheng, Wei , Long, Jirong, O’Brien, Katie M. , Sandler, Dale P. , Kitahara, Cari M. , Anderson, Garnet L. , Lee, I-Min, García‐Closas, Montserrat , Chatterjee, Nilanjan

Mayo Clinic

No container title available | August 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.08.20.26360899 Get It

Background: Several breast cancer (BC) risk prediction models have been developed to provide personal risk assessments. Though individually validated, their performance has not been systematically evaluated across a wide range of populations or ages. Methods: We harmonized individual-level baseline questionnaire data and incident BC diagnoses from 21 cohorts from North America, Europe, and Australia participating in the Breast Cancer Risk Prediction Project. Five-year absolute risk of invasive BC was estimated for five established risk prediction models using classical risk factors only. Discrimination was evaluated by area under the curve (AUC). Calibration was assessed using average and risk-decile specific expected to observed (E/O) ratios. Performance metrics were meta-analyzed across cohorts and models. Metaregression tested associations between cohort characteristics and performance metrics. Results: This analysis included 1,595,977 women aged 20-75 years, enrolled in studies between 1976-2015, with 19,062 (1.2%) invasive BC cases ascertained within 5 years from exposure assessment. Age-adjusted AUCs were similar across models and cohorts (pooled AUCs by model: 0.57-0.58), while E/O ratios varied substantially (pooled E/O ratios by model: 0.83-1.25). Overestimation was common among predicted high-risk individuals (>3%). No appreciable differences in model performance by cohort age, birth year, race, and variable missingness emerged. Calibration improved after assigning race-specific incidence rates. Conclusion: Existing BC risk prediction models provided similar risk discrimination across multiple cohorts, although there was overestimation of risk for high-risk individuals. Performance variation across cohorts was not driven by specific characteristics, which supports development of a unified risk model for diverse populations that leverages appropriate incidence rates.
Refining MMA Screening in the Dutch Newborn Screening Program: Lessons from Vitamin B12 Deficiency and Genetic Cases
Meijer, Nils W. F., Koop, Klaas , Maase, Rose, Hall, Patricia L., Visser, Wouter F. , Oussoren, Esmeralda, Heiner‐Fokkema, M. Rebecca , Velden, Monique G.M. de Sain–van der , Bosch, Annet M , Heiner-Fokkema, M Rebecca , de Sain-van der Velden, Monique G M

Mayo Clinic

International Journal of Neonatal Screening | August 21, 2026 | Volume: 12 | Issue: 3 | Pages: 69

10.3390/ijns12030069 | PMID 42647256 Get It

Since October 2019, screening for methylmalonic acidemia (MMA) has been implemented in the Dutch Newborn Screening (NBS) program. Since implementation, most referrals for MMA have been the result of (maternal) vitamin B12 deficiency. Although vitamin B12 deficiency is an important condition and early detection can confer health benefits, its identification was not the original objective of the screening. We therefore examined whether genetic forms of MMA can be distinguished from acquired forms. Early distinction between these forms is essential for guiding clinical management, informing prognosis, and enabling appropriate genetic counseling. Specifically, we tested whether the use of Collaborative Laboratory Integrated Reports (CLIR) to complement NBS results improved specificity of the test for genetic MMAs. We found that with the use of CLIR, genetic conditions including methylmalonyl-CoA mutase (mut) deficiency and cobalamin (cbl) A, B, C and D deficiency can be partially differentiated from acquired causes. This results in a significant reduction in the number of second-tier tests required. However, this approach may also exclude certain other genetic causes. Based on all findings, we provide considerations and implications for MMA screening that may inform decision-makers in (other) NBS programs.
The Algorithms for Mapping Elastic Modulus (aMEM) Challenge
Civale, John , Meyer, T., Bamber, Jeffrey C. , Palmeri, Mark L. , Tzschatzsch, H., Harris, E. J., Harris, Emma , Meyer, Tom , Urban, Matthew W. , Tzschätzsch, Heiko , Harris, E.J.

Mayo Clinic

IEEE Open Journal of Ultrasonics, Ferroelectrics, and Frequency Control | August 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/ojuffc.2026.3724826 Get It

Gamification as an In Situ Educational Strategy for Nurses in the Clinical Setting
Gagliasso, Rachel M., Hinkle, Lacy J., Schammel, Andrea L., Stevens, Lauren R., Thurmes, Emma L., Rohwer, Bobbi Jo R., Gagliasso, Rachel

Mayo Clinic

The Journal of Continuing Education in Nursing | August 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-5

10.3928/00220124-20260615-02 | PMID 42600082 Get It

Background: Traditional educational methods often require protected time away from clinical duties, can be difficult to attend because of staffing or scheduling constraints, and may not consistently engage learners or meet individual learning needs. This article describes a gamified in situ microlearning approach to nursing professional development within the clinical practice setting that was designed to improve confidence and knowledge retention while maintaining staff satisfaction. Method: The educational intervention was provided in the clinical setting to avoid scheduling conflicts and interruptions in care. Results: Education on 18 topics was provided over 12 months. The gamified microlearning was associated with increased self-reported confidence without negatively impacting satisfaction. Conclusion: Gamified in situ microlearning can serve as a valuable adjunct to nursing professional development.